Integra Lifesciences Holdings Corp (NAS:IART)
$ 24.8 -0.64 (-2.51%) Market Cap: 1.91 Bil Enterprise Value: 3.68 Bil PE Ratio: 0 PB Ratio: 1.26 GF Score: 71/100

Integra Lifesciences Holdings Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 01:20PM GMT
Release Date Price: $67.78 (+3.24%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. I'm Robbie Marcus, med tech analyst at JPMorgan. Very happy to introduce our next session, which is Integra LifeSciences. We're going to have CEO, Pete Arduini, during the presentation. We'll have the management team join us after. Before I hand it over, everybody can go to the conference website to grab their slides. Can ask a question there or e-mail me or chat me on Bloomberg, and I'll do my best to get to all of them in the Q&A session. So with that, Pete, I'm going to hand it over to you, and I'll see you for Q&A.

Peter J. Arduini
Integra LifeSciences Holdings Corporation - President, CEO & Director

Thanks, Robbie, and good morning, everyone. The presentation, the first 2 to 3 pages, we actually have our safe harbor and looking forward statements. You can see those for your review on Pages 2 and 3.

But let's start the presentation. And if you turn to Slide 4 in the slide deck titled Integra at a Glance, I'll start there. We are a global

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot